The relationship between smoking, psoriasis and psoriatic arthritis

References

• Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3(2):121–128.
   PubMedGoogle Scholar
• Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2018 Jun 18. doi:10.1016/j.jaad.2018.06.027 [ Epub ahead of print].
   PubMedGoogle Scholar
• Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957–970.
   PubMed Web of Science ®Google Scholar
• Naldi L, Mercuri SR. Smoking and psoriasis: from epidemiology to pathomechanisms. J Invest Dermatol. 2009;129:2741–2743.
   PubMed Web of Science ®Google Scholar
• Brandt AM. The cigarette century: the rise, fall, and deadly persistence of the product that defined America. New York, NY: Basic Books; 2007.
   Google Scholar
• U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
   Google Scholar
• International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risks to humans: tobacco smoke and involuntary smoking. Vol. 83. Lyon (France): International Agency for Research on Cancer; 2004.
   Google Scholar
• Morris PB, Ference BA, Jahangir E, et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American college of cardiology. J Am Coll Cardiol. 2015;66(12):1378–1391.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015;385(9979):1778–1788.
   PubMed Web of Science ®Google Scholar
• Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372–377.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Gallus S, Naldi L. Tobacco and skin disease. Dermatology. 2005;211:81–83.
   PubMed Web of Science ®Google Scholar
• de Hair MJ, Landewé RB, van de Sande MG, et al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis. 2013;72:1654–1658.
   PubMed Web of Science ®Google Scholar
• Videm V, Cortes A, Thomas R, et al. Current smoking is associated with incident ankylosing spondylitis – the HUNT population-based Norwegian health study. J Rheumatol. 2014;41:2041–2048.
   PubMedGoogle Scholar
• Kaut IK, Abourazzak FE, Jamila E, et al. Axial spondyloarthritis and cigarette smoking. Open Rheumatol J. 2017;11:53–61.
   PubMedGoogle Scholar
• Berkowitz L, Schultz BM, Salazar GA, et al. Impact of cigarette smoking on the gastrointestinal tract inflammation: opposing effects in Crohn’s Disease and ulcerative colitis. Front Immunol. 2018;30:9–74.
   Google Scholar
• Li T, Wu S, Zhang H, et al. Activation of nicotinic receptors inhibits TNF-α-induced production of pro-inflammatory mediators through the JAK2/STAT3 signaling pathway in fibroblast-like synoviocytes. Inflammation. 2015;38:1424–1433.
   PubMed Web of Science ®Google Scholar
• Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. Boca Raton (FL): CRC Press, Taylor & Francis Group; 2009.
   Google Scholar
• Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362:2295–2303.
   PubMed Web of Science ®Google Scholar
• Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control. 2003;12:424–430.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Okamoto H, Iwamoto T, et al. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford). 2008;47:1317–1322.
   PubMed Web of Science ®Google Scholar
• Lee J, Jeong H, Park EJ, et al. A role for benzo(a)pyrene and slug in invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis: a potential molecular link between smoking and radiographic progression. Joint Bone Spine. 2013;80:621–625.
   PubMed Web of Science ®Google Scholar
• Gao Z, Nissen JC, Ji K, et al. The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components. PLoS One. 2014;9:e107979.
   PubMed Web of Science ®Google Scholar
• Bekki K, Uchiyama S, Ohta K, et al. Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health. 2014;11:11192–11200.
   PubMed Web of Science ®Google Scholar
• Mucha L, Stephenson J, Morandi N, et al. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med. 2006;3:279–291.
   PubMedGoogle Scholar
• Caporaso N, Gu F, Chatterjee N, et al. Genomewide and candidate gene association study of cigarette smoking behaviors. PLoS One. 2009;4:e4653.
   PubMed Web of Science ®Google Scholar
• Lutz SM, Hokanson JE. Genetic influences on smoking and clinical disease. Understanding behavioral and biological pathways with mediation analysis. Ann Am Thorac Soc. 2014;11:1082–1083.
   PubMedGoogle Scholar
• Li MD, Cheng R, Ma JZ, et al. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction. 2003;98:23–31.
   PubMed Web of Science ®Google Scholar
• Loukola A, Hallfors J, Korhonen T, et al. Genetics and smoking. Curr Addict Rep. 2014;1:75–82.
   PubMedGoogle Scholar
• Gilbert DG, Gilbert BO. Personality, psychopathology, and nicotine response as mediators of the genetics of smoking. Behavior Genetics. 1995;25:133–147.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Harskamp CT, Dhillon JS, et al. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170:304–314.
   PubMed Web of Science ®Google Scholar
• Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61–67.
   PubMed Web of Science ®Google Scholar
• Jin Y, Yang S, Zhang F, et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case–control study in China. J Eur Acad Dermatol Venereol. 2009;23:132–137.
   PubMed Web of Science ®Google Scholar
• Yin XY, Cheng H, Wang WJ, et al. TNIP1/ANXA6 and CSMD1 variants interacting with cigarette smoking, alcohol intake affect risk of psoriasis. J Dermatol Sci. 2013;70:94–98.
   PubMed Web of Science ®Google Scholar
• Quan C, Zhu K-J, Zhang C, et al. Combined effects of the BDNF rs6265 (Val66Met) polymorphism and environment risk factors on psoriasis vulgaris. Mol Biol Rep. 2014;41:7015–7022.
   PubMed Web of Science ®Google Scholar
• Krämer U, Esser C. Cigarette smoking, metabolic gene polymorphism, and psoriasis. J Invest Dermatol. 2006;126:693–694.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Armstrong EJ, Fuller EN, et al. Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol. 2011;165:1162–1168.
   PubMed Web of Science ®Google Scholar
• Yanagita M, Kobayashi R, Kojima Y, et al. Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation. Cell Immunol. 2012;274:26–33.
   PubMed Web of Science ®Google Scholar
• Jeong SH, Park JH, Kim JN, et al. Up-regulation of TNF-alpha secretion by cigarette smoke is mediated by Egr-1 in HaCaT human keratinocytes. Exp Dermatol. 2010;19(8):e206–e212.
   PubMed Web of Science ®Google Scholar
• Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10:219–230.
   PubMed Web of Science ®Google Scholar
• Tey HL, Ee HL, Tan AS, et al. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010;37:426–430.
   PubMed Web of Science ®Google Scholar
• Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012;71:219–224.
   PubMed Web of Science ®Google Scholar
• Li W, Han J, Qureshi AA. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71:804–808.
   PubMed Web of Science ®Google Scholar
• Nguyen UDT, Zhang Y, Lu N, et al. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018;77:119–123.
   PubMed Web of Science ®Google Scholar
• Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol. 2005;141:1580–1584.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK, Watteel GN. Cigarette smoking in men may be a risk factor for increased psoriasis of the extremities. Br J Dermatol. 1996;135:859–860.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis. 2000;66:348–352.
   PubMed Web of Science ®Google Scholar
• Thorneloe RJ, Bundy C, Griffiths CEM, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168:20–31.
   PubMed Web of Science ®Google Scholar
• Di Lernia V, Ricci C, Lallas A, et al. Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study. J Dermatolog Treat. 2014;25:73–74.
   PubMed Web of Science ®Google Scholar
• Zhu KJ, Quan C, Zhang C, et al. Combined effect between CHRNB3-CHRNA6 region gene variant (rs6474412) and smoking in psoriasis vulgaris severity. Gene. 2014;544:123–127.
   PubMed Web of Science ®Google Scholar
• Umana IC, Daniele CA, Miller BA, et al. Nicotinic modulation of descending pain control circuitry. Pain. 2017;158:1938–1950.
   PubMed Web of Science ®Google Scholar
• Bremander A, Jacobsson LT, Bergman S, et al. Smoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort. Clin Rheumatol. 2015;34:579–583.
   PubMedGoogle Scholar
• Tillett W, Jadon D, Shaddick G, et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis. 2013;72:1358–1361.
   PubMed Web of Science ®Google Scholar
• Højgaard P, Glintborg B, Hetland ML, et al. Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registry. Ann Rheum Dis. 2015;74:2130–2136.
   PubMed Web of Science ®Google Scholar
• Soubrier M, Pereira B, Frayssac T, et al. Psoriatic arthritis treated by anti TNFs: a monocentric trial of 102 cases in Auvergne, France. Clin Exp Rheumatol. 2016;34:1059–1064.
   PubMed Web of Science ®Google Scholar
• Naldi L, Chatenoud L. Psoriasis and cancer: more than a chance link. Ann Dermatol Venereol. 2006;133:221–223.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Zúñiga MJM, Ía-Perdomo HA. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. Am Acad Dermatol. 2017;77:657–666.
   PubMed Web of Science ®Google Scholar
• Li Z, Yang X, Yang J, et al. The cohort study on prediction of incidence of all-cause mortality by metabolic syndrome. PLoS One. 2016;11:e0154990.
   PubMed Web of Science ®Google Scholar
• Caso F, Del P, Oliviero F, et al. Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study. Clin Rheumatol. 2018;37:579–586.
   PubMed Web of Science ®Google Scholar
• Kong C, Nimmo L, Elatrozy T, et al. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in type 2 diabetes. Atherosclerosis. 2001;156:373–378.
   PubMed Web of Science ®Google Scholar
• Skudutyte-Rysstad R, Slevolden EM, Hansen BF, et al. Association between moderate to severe psoriasis and periodontitis in a Scandinavian population. BMC Oral Health. 2014;14:139.
   PubMed Web of Science ®Google Scholar
• Genco RJ, Borgnakke WS. Rsk factors for periodontal disease.-. Periodontol. 2000;62(59–94):2013.
   Google Scholar
• Antal M, Braunitzer G, Mattheos N, et al. Smoking as a permissive factor of periodontal disease in psoriasis. PLoS One. 2014;14:139.
   Google Scholar
• Kalb RE, Fiorentino DF, Lebwohl MG, et al. Risk of serious infection with biologic and systemic treatment of psoriasis: results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol. 2015;15:961–969.
   Google Scholar
• Pugliese D, Guidi L, Ferraro PM, et al. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther. 2015;42:880–888.
   PubMed Web of Science ®Google Scholar
• Nguyen UDT, Zhang Y, Choi HK. Response to: ‘Smoking paradox in the development of psoriatic arthritis among patients with psoriasis’ by Lee and Song. Ann Rheum Dis. 2018 Sep 8. DOI:10.1007/s00198-018-4700-9.
   Google Scholar
• Owczarczyk-Saczonek AB, Nowiki R. The association between smokingand the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years. Postepy Dermatol Alergol. 2015;32:331–336.
   PubMed Web of Science ®Google Scholar
• Davidovidici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin diseases and co-morbid conditions. J Invest Dermatol. 2010;130:1785–1796.
   PubMed Web of Science ®Google Scholar
• Norcross JC, Krebs PM, Prochaska JO. Stages of change. J Clin Psychol. 2011;67:143–154.
   PubMed Web of Science ®Google Scholar
• Fiore MC, Baker TB. Clinical practice. Treating smokers in the health care setting. N Engl J Med. 2011;365:1222–1231.
   PubMed Web of Science ®Google Scholar
• Naldi L. Lifestyle intervention should be an essential component of medical care for skin disease: a challenging task. Br J Dermatol. 2014;171:934–935.
   PubMed Web of Science ®Google Scholar